Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sentinel’s tall order

This article was originally published in The Gray Sheet

Executive Summary

FDA plans to request quotations June 1 from vendors interested in creating an active medical product surveillance system for the agency's Sentinel post-market safety initiative, FDA says in a May 15 FedBizOpps.gov notice. The selected vendor would develop a system to detect and analyze adverse event data from automated health care data systems, including electronic health records, claims databases and registries. Data should contain drug and biologic utilization, and ideally medical device utilization information, as well
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027487

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel